Recurrent miscarriages: caution regarding development of clinical trials using low molecular weight heparin and pregnancy.
Dipika
D
Misra
Louis
L
Aledort
D000026:Abortion, Habitual / Q000517:prevention & control*; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D017984:Enoxaparin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D065427:Factor Xa Inhibitors; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000097:blood / Q000517:prevention & control; D012107:Research Design; D020246:Venous Thrombosis / Q000097:blood / Q000517:prevention & control; D055815:Young Adult
D000925:Anticoagulants; D017984:Enoxaparin; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight